CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today reported financial and operating results for its first quarter ended March 31, 2016. Highlights for the quarter included:
•Achieved first quarter revenue of $30.4 million, 57% year-over-year growth;
• Reported 8,985 clinical tests in the first quarter, 14% year-over-year growth;
•Achieved first quarter revenue of $30.4 million, 57% year-over-year growth;
• Reported 8,985 clinical tests in the first quarter, 14% year-over-year growth;
